Treatment and prevention of Lyme disease: guidelines

2000 ◽  
Vol 279 (1) ◽  
pp. 5-5
Keyword(s):  
Lyme Disease ◽  
Treatment And Prevention

Diagnosis, Treatment, and Prevention of Lyme Disease

JAMA ◽  
1998 ◽  
Vol 280 (12) ◽  
pp. 1049 ◽  
Author(s):  
Robert C. Bransfield
Keyword(s):  
Lyme Disease ◽  
Treatment And Prevention

scholarly journals The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

2006 ◽  
Vol 43 (9) ◽  
pp. 1089-1134 ◽  
Author(s):  
Gary P. Wormser ◽  
Raymond J. Dattwyler ◽  
Eugene D. Shapiro ◽  
John J. Halperin ◽  
Allen C. Steere ◽  
...  
Keyword(s):  
Lyme Disease ◽  
Infectious Diseases ◽  
Health Care Providers ◽  
Treatment Guidelines ◽  
Clinical Manifestations ◽  
Previous Treatment ◽  
Care Providers ◽  
Human Granulocytic Anaplasmosis ◽  
Treatment And Prevention ◽  
Granulocytic Anaplasmosis

Abstract Evidence-based guidelines for the management of patients with Lyme disease, human granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and babesiosis were prepared by an expert panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 31[Suppl 1]:1–14). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. For each of these Ixodes tickborne infections, information is provided about prevention, epidemiology, clinical manifestations, diagnosis, and treatment. Tables list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease and provide a partial list of therapies to be avoided. A definition of post–Lyme disease syndrome is proposed.

Diagnosis, Treatment, and Prevention Practices for Lyme Disease by Clinicians, United States, 2013-2015

2021 ◽  
pp. 003335492097323
Author(s):  
Alyssa R. Beck ◽  
Grace E. Marx ◽  
Alison F. Hinckley
Keyword(s):  
United States ◽  
Health Care ◽  
Lyme Disease ◽  
Disease Diagnosis ◽  
Tick Bite ◽  
Clinical Practices ◽  
Tick Bites ◽  
Treatment And Prevention ◽  
High Incidence ◽  
Disease Testing

Objectives Although tick-borne diseases account for a large number of health care visits in the United States, clinical practices for tick bite and Lyme disease treatment and prevention are not well understood. The objective of this study was to better understand factors associated with clinical practices related to tick bites and Lyme disease. Methods In 2013-2015, questions about tick-bite evaluation, Lyme disease diagnosis and treatment, appropriate use of Lyme disease testing, and tick-bite prevention were included in Porter Novelli’s DocStyles survey, a nationally representative annual web-based survey of health care providers. We performed analyses of responses by provider license type and state-level incidence (high or low) of Lyme disease in 2019. Results A total of 4517 providers were surveyed across the 3 study years. Overall, 80.9% of providers reported that they had evaluated at least 1 patient for a tick bite, 47.6% had diagnosed at least 1 patient with Lyme disease, and 61.9% had treated at least 1 patient for Lyme disease in the previous year. Providers from states with a high incidence of Lyme disease saw more patients for tick bites and Lyme disease than providers from states with a low incidence of Lyme disease. Few providers correctly chose Lyme disease testing as clinically useful in the hypothetical case of a patient from a state with a high incidence of Lyme disease with an arthritic knee (36.0%) or with new-onset atrioventricular block (39.5%), and respondents across all provider types incorrectly chose testing when not clinically indicated. Most providers (69.7%) reported routinely recommending tick-bite prevention methods to patients. Conclusions Many providers evaluate patients for tick bites and treat patients for Lyme disease, but knowledge about appropriate testing is low. Providers may benefit from tailored education about appropriate Lyme disease diagnosis, testing, and effective tick-bite prevention.

scholarly journals Lyme disease: modern approaches to treatment and prevention (based on international recommendations of 2020)

2022 ◽  
Vol 66 (9-10) ◽  
pp. 57-63
Author(s):  
B. S. Belov ◽  
L. P. Ananyeva
Keyword(s):  
Lyme Disease ◽  
Erythema Migrans ◽  
Clinical Manifestations ◽  
The United States ◽  
Cefuroxime Axetil ◽  
Duration Of Treatment ◽  
American College Of Rheumatology ◽  
Treatment And Prevention ◽  
Medical Importance ◽  
American Academy Of Neurology

Lyme disease (LD) or tick-borne borreliosis affects thousands of people every year in different regions of the world, primarily in the United States and Europe. Given the great social and medical importance of this problem, an updated version of the clinical guidelines for the prevention, diagnosis and treatment of PD was published in November 2020 by a committee of experts of the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN) and the American College of Rheumatology (ACR). This article discusses the main issues of the use of antibacterial drugs in LD. The most commonly used medications are doxycycline, amoxicillin, cefuroxime axetil, and ceftriaxone. Patients with erythema migrans receive appropriate antibiotics for 7–14 days, depending on the medication used. In case of other clinical manifestations of LD, the duration of treatment is extended to 14–28 days. Antibiotic prophylaxis is carried out using a single oral dose of 200 mg doxycycline for adults and 4.4 mg/kg (with a maximum of 200 mg) for children. This treatment scheme is highly efficient, easy to administer, and has a relatively low risk of adverse events.

scholarly journals Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis

JAMA ◽  
2016 ◽  
Vol 315 (16) ◽  
pp. 1767 ◽  
Author(s):  
Edgar Sanchez ◽  
Edouard Vannier ◽  
Gary P. Wormser ◽  
Linden T. Hu
Keyword(s):  
Lyme Disease ◽  
Human Granulocytic Anaplasmosis ◽  
Treatment And Prevention ◽  
Granulocytic Anaplasmosis

scholarly journals ACVIM Small Animal Consensus Statement on Lyme Disease in Dogs: Diagnosis, Treatment, and Prevention

2006 ◽  
Vol 20 (2) ◽  
pp. 422-434 ◽  
Author(s):  
Meryl P. Littman ◽  
Richard E. Goldstein ◽  
Mary A. Labato ◽  
Michael R. Lappin ◽  
George E. Moore
Keyword(s):  
Lyme Disease ◽  
Consensus Statement ◽  
Small Animal ◽  
Treatment And Prevention
Sign in / Sign up

Export Citation Format

Share Document